PR
NASDAQ · PRPO
Precipio, Inc.
Healthcare · Medical - Diagnostics & Research
$25.60
Up+$1.31 (+5.12%)
Updated Sep 11, 2026, 12:40 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 37.66M
- P/E ratio
- -31.99
- Dividend yield
- 0.00%
- 52-week range
- $16.00 – $33.63
- Volume
- 132.82K
- Avg. volume
- 15.04K
Price performance
PRPO price history
1M range · 19 trading sessions · Daily adjusted prices
PRPO closed at $25.60 after 19 trading sessions, up 10.30% for the selected period.
- Last close
- $25.60
- Period change
- +10.30%
- Period low
- $23.21
- Period high
- $31.12
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 9, 2026 | $27.10 | $27.10 | $25.495 | $25.60 | 132.82K |
| Sep 8, 2026 | $26.87 | $27.80 | $25.63 | $27.25 | 304.06K |
| Sep 4, 2026 | $26.11 | $27.90 | $24.48 | $27.40 | 114.54K |
| Sep 3, 2026 | $27.67 | $27.96 | $25.91 | $26.12 | 423.79K |
| Sep 2, 2026 | $27.93 | $28.16 | $26.77 | $27.50 | 237.05K |
| Sep 1, 2026 | $27.41 | $28.80 | $27.06 | $27.765 | 211.24K |
| Aug 31, 2026 | $28.85 | $29.905 | $27.27 | $27.69 | 94.5K |
| Aug 28, 2026 | $29.38 | $30.55 | $28.60 | $28.85 | 205.15K |
| Aug 27, 2026 | $30.30 | $30.39 | $28.85 | $29.29 | 36.69K |
| Aug 26, 2026 | $30.43 | $32.57 | $29.57 | $30.405 | 91.03K |
| Aug 25, 2026 | $30.96 | $31.82 | $30.07 | $30.85 | 258.27K |
| Aug 24, 2026 | $30.45 | $31.41 | $29.54 | $31.12 | 29.69K |
| Aug 21, 2026 | $29.48 | $30.45 | $27.0001 | $30.45 | 69.65K |
| Aug 20, 2026 | $27.76 | $29.60 | $27.10 | $29.43 | 366.64K |
| Aug 19, 2026 | $25.01 | $27.85 | $24.63 | $27.85 | 92.81K |
| Aug 18, 2026 | $24.05 | $25.64 | $23.90 | $24.69 | 331.44K |
| Aug 17, 2026 | $23.15 | $26.75 | $22.96 | $23.90 | 49.75K |
| Aug 14, 2026 | $23.24 | $24.48 | $22.52 | $23.50 | 75.81K |
| Aug 13, 2026 | $22.89 | $23.415 | $22.23 | $23.21 | 411.28K |
Latest PRPO news
The latest Smart Investors Daily articles mentioning PRPO.
Stock researchResearch & News · SEC Filings
Loading stock research…
